Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Pharmaceutical
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
September 01, 2010
No release date set for Atomoxetine
Pfizer to Acquire FoldRx Pharmaceuticals
September 01, 2010
Lead product candidate tafamidis meglumine in EU Registration
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
August 31, 2010
Second FDA-Approved Drug Based on MonoSol Rx's PharmFilm® Technology
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
August 31, 2010
Reduces the review time goal from 10 months to six months
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
August 30, 2010
Original PDUFA goal date was August 30, 2010
Meda acquires Alaven, a US specialty pharma company
August 30, 2010
Strengthens position in the strategic US market
Medicis Announces Approval of Additional Strengths of Solodyn(R)
August 30, 2010
Three New Strengths Provide Greater Solodyn Dosing Precision
Novartis receives FDA approval of Tekamlo
August 27, 2010
A single-pill combination of aliskiren and amlodipine to treat high blood pressure
Cypress Bioscience Acquires Novel Intranasal Carbetocin Therapy for Autism
August 26, 2010
Therapy May Represent Novel Approach to Treating the Repetitive Behaviors and Social Deficits of Autism
Novartis Completes Purchase from Nestlé of Majority Interest in Alcon
August 26, 2010
Novartis now controls approximately 77 percent of Alcon's outstanding shares
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
August 25, 2010
NovoDose Free to Doctors through iTunes
Eisai Announces Positive Phase III Trial Results for Perampanel in Epilepsy
August 24, 2010
First in a series of Phase III clinical trials
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
August 23, 2010
Vagifem® 10 mcg replaces Vagifem® 25 mcg dose
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
August 23, 2010
Actively recruiting top talent to support US market penetration
FDA panel recommends broader use of Eli Lilly's Cymbalta
August 20, 2010
Committee votes positively regarding the overall safety profile of Cymbalta
Perrigo Confirms Filing for Clobetasol Shampoo
August 19, 2010
Announcement of Patent Infringement Lawsuit by Galderma
Biogen Idec and Knopp Neurosciences Announce License Agreement for Late-Stage ALS Drug Candidate
August 18, 2010
Biogen Idec expects to initiate Phase 3 program in the first half of 2011
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
August 17, 2010
Decision does not affect other Lilly Alzheimer's compounds in development
DUSA Pharmaceuticals Receives Response From FDA on Orphan Drug Designation Status
August 06, 2010
Orphan Drug Designation must target a disease that affects fewer than 200,000 patients in the U.S.
Cypress Bioscience Responds to Unsolicited, Non-Binding Proposal and Recent Letter From Ramius LLC
August 06, 2010
Proposal thoroughly review by Board of Directors and financial and legal advisors
Depomed Licenses GLUMETZA(R) Data and Acuform(R) Technology
August 05, 2010
Depomed will receive a $5 million upfront license fee
FDA Approves New Taxotere® (docetaxel) Injection Concentrate Formulation
August 05, 2010
1-vial Taxotere offers simplified preparation
Cypress Bioscience Announces Agreement to Discontinue Co-Promotion of Savella(R) With Forest Laboratories
August 04, 2010
Withdrawal From Commercial Market Will Result in Annual Savings of $10 Million
Victory Pharma Completes Acquisition of Assets of MiddleBrook Pharmaceuticals
August 03, 2010
Company Expands Product Portfolio, Adds Drug Delivery Technology
FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
August 02, 2010
Important Regulatory Milestone for Xeomin®
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
August 02, 2010
Company Adds Ronald M. Evans and David J. Mangelsdorf to Scientific Advisory Board
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
July 29, 2010
CUVPOSA™ was designated an Orphan Drug by the FDA
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
July 28, 2010
"Dry" Nasal Spray Met Primary and Secondary Endpoints
Antares Pharma Announces Positive Top Line Results From Its Pivotal Phase 3 Study of Anturol Gel for the Treatment of Overactive Bladder
July 27, 2010
Company on Target to File NDA in 2010
Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture
July 27, 2010
Proposed JV to be called Merial-Intervet
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development